{"id":25245,"date":"2025-11-30T16:58:35","date_gmt":"2025-11-30T15:58:35","guid":{"rendered":"https:\/\/jegharkraeft.dk\/?p=25245"},"modified":"2025-12-18T17:25:42","modified_gmt":"2025-12-18T16:25:42","slug":"nyrebaekken-og-urinlederkraeft","status":"publish","type":"post","link":"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/","title":{"rendered":"Nyreb\u00e6kken- og Urinlederkr\u00e6ft. Kr\u00e6ft i nyreb\u00e6kken. Kr\u00e6ft i urinleder. Urotelialt karcinom. Blod i urinen. Nefroureterektomi. Smerter i flanken. Ureteroskopi. \u00d8vre urinveje tumor."},"content":{"rendered":"\n<div class=\"wp-block-group alignfull is-style-section-5 has-contrast-color has-base-background-color has-text-color has-background has-link-color wp-elements-e43411cfd86eb0e9f2bcc5ea52eed167 has-global-padding is-layout-constrained wp-block-group-is-layout-constrained is-style-section-5--2\" id=\"menu\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--50);padding-bottom:var(--wp--preset--spacing--50)\">\n<div class=\"wp-block-columns alignwide is-layout-flex wp-container-core-columns-is-layout-ca2dd60b wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h2 class=\"wp-block-heading has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-890e3c045e088b3f0eb4325834726146\" id=\"diagnose\"><span class=\"ez-toc-section\" id=\"Diagnose\"><\/span><a href=\"https:\/\/jegharkraeft.dk\/diagnose\" data-type=\"link\" data-id=\"https:\/\/jegharkraeft.dk\/diagnose\">Diagnose<\/a><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"wp-block-group has-custom-interne-links-color has-text-color has-link-color wp-elements-29722141be8cdfb7704ff7904fc1421f has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<ol class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-23b4cb6a772ae26487853362438f6f9e\"><a href=\"https:\/\/jegharkraeft.dk\/hvad-er-kraeft\">Hvad er kr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-e67d1145b53f961ce781291509c20672\"><a href=\"https:\/\/jegharkraeft.dk\/symptomer\">Symptomer<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/jegharkraeft.dk\/kraefttyper\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-hvid-tekst-color\">Kr\u00e6fttyper<\/mark><\/a>\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-85161ed720c669ff95d38a1e09f286cd\"><a href=\"https:\/\/jegharkraeft.dk\/bugspytkirtelkraeft\">3.A Ford\u00f8jelsesorganer<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-f60c1cb33ab94504f06a3d567eac7ef1\"><a href=\"https:\/\/jegharkraeft.dk\/brystkraeft\">3.B K\u00f8nsorganer<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-189b11dfa0d506668905cf357de2955e\"><a href=\"https:\/\/jegharkraeft.dk\/hoved-halskraeft\">3.C Hovedet og halsen<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-466ad727d686907eeeb5adb4e82a8f02\"><a href=\"https:\/\/jegharkraeft.dk\/leukaemi\">3.D Blod og lymfe<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-45e7f5d534f1edcfb30bff2bf7c223a7\"><a href=\"https:\/\/jegharkraeft.dk\/hudkraeft\">3.E Hud<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/jegharkraeft.dk\/blaerekraeft\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-hvid-tekst-color\">3.F Andre organer<\/mark><\/a>\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-bb60f52c16f8a387cc3816e15ff24669\"><a href=\"https:\/\/jegharkraeft.dk\/bloeddelssarkom\/\">Bl\u00f8ddelssarkom<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-76f64143737cc99423035bb07afad663\"><a href=\"https:\/\/jegharkraeft.dk\/gliomer\/\">Hjernekr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-00cde6c21527c35705a21f8641de65ea\"><a href=\"https:\/\/jegharkraeft.dk\/knoglekraeft\">Knoglekr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-591e6dd1e4cc69f5e653af6a30cfe6e4\"><a href=\"https:\/\/jegharkraeft.dk\/lungehindekraeft\/\">Lungehindekr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-41a9e21861544f1622998194e6aa00bc\"><a href=\"https:\/\/jegharkraeft.dk\/lungekraeft\">Lungekr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-e3edd32d9638b180066e1ed8ff192548\"><a href=\"https:\/\/jegharkraeft.dk\/neuroblastom\">Neuroblastom<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-7d8e902ba055e23007e3ddeb10c3d0f3\"><a href=\"https:\/\/jegharkraeft.dk\/nyrekraeft\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-hvid-tekst-color\">Nyrekr\u00e6ft<\/mark><\/a>\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-849366762228d57c56554da0ea0cc4b4\"><a href=\"https:\/\/jegharkraeft.dk\/blaerekraeft\/\">Bl\u00e6rekr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-her-st-r-du-color has-text-color has-link-color wp-elements-daa6944302867643366b0898d5f0b279\"><a href=\"#nyre-baekken-urinlederkraeft\">Nyreb\u00e6kken- og Urinlederkr\u00e6ft (scroll ned)<\/a><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-9f39b38cbaffa90bb3bc318eeb5e6369\"><a href=\"https:\/\/jegharkraeft.dk\/wilms-tumor\/\">Wilms tumor (nefroblastom)<\/a><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-ebc359816354c31432319643069582c2\"><a href=\"https:\/\/jegharkraeft.dk\/alk-mutation\">3.G Genetiske mutationer<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-78e4bd2acafb448af2bdb7bef5605441\"><a href=\"https:\/\/jegharkraeft.dk\/parasittens-vej-til-kraeft\">3.H Infektionsrelateret kr\u00e6ft<\/a><a href=\"https:\/\/jegharkraeft.dk\/kraefttyper\"><\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-59e0bb6b8f0bb69496e56e726a74082d\"><a href=\"https:\/\/jegharkraeft.dk\/binyrekraeft\">3.I Endokrine kirtler<\/a><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-60a73b2d8f5bf0cd1715ac7d6fc440fc\"><a href=\"https:\/\/jegharkraeft.dk\/kraeftformer\">Kr\u00e6ftformer<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-91308c4a8398d249f000f70fe17bcf02\"><a href=\"https:\/\/jegharkraeft.dk\/undersoegelser\">Unders\u00f8gelser<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-87af2b6def054da5be4a6efd940116a1\"><a href=\"https:\/\/jegharkraeft.dk\/second-opinion-1\">Second Opinion<\/a><\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1280\" height=\"905\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft2.jpg\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved nogle fr\u00f8ranker fra en gren.\" class=\"wp-image-25252\" style=\"aspect-ratio:3\/2;object-fit:cover;width:550px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft2.jpg 1280w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft2-600x424.jpg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft2-300x212.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft2-1024x724.jpg 1024w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft2-768x543.jpg 768w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-style-default has-global-padding is-layout-constrained wp-container-core-group-is-layout-b040ace0 wp-block-group-is-layout-constrained has-background\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--60);padding-left:var(--wp--preset--spacing--20);background-image:url(&apos;https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft2.jpg&apos;);background-size:cover;\">\n<div class=\"gb-element-906497af\">\n<h1 class=\"wp-block-heading\" id=\"nyre-baekken-urinlederkraeft\"><span class=\"ez-toc-section\" id=\"Nyrebaekken-_og_Urinlederkraeft\"><\/span>Nyreb\u00e6kken- og Urinlederkr\u00e6ft<span class=\"ez-toc-section-end\"><\/span><\/h1>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-custom-sort-tekst-color has-alpha-channel-opacity has-custom-sort-tekst-background-color has-background\"\/>\n\n\n\n<h4 class=\"wp-block-heading\">Resum\u00e9 om kr\u00e6ft i nyreb\u00e6kken og urinleder<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Sj\u00e6lden placering:<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sygdommen opst\u00e5r i slimhinden, der transporterer urinen fra nyren ned til bl\u00e6ren. Det er biologisk set samme type kr\u00e6ft som bl\u00e6rekr\u00e6ft, men den sidder et mere kritisk sted t\u00e6t p\u00e5 nyren. <\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vigtigste signal:<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Synligt blod i urinen er det hyppigste symptom. Smerter i flanken kan opst\u00e5, hvis svulsten blokerer for urinen, s\u00e5 trykket stiger i nyren. <\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Omfattende operation:<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Standardbehandlingen er oftest fjernelse af b\u00e5de nyre og urinleder. Dette er n\u00f8dvendigt for at forhindre, at sygdommen vender tilbage i resterne af urinvejen.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-custom-sort-tekst-color has-alpha-channel-opacity has-custom-sort-tekst-background-color has-background\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Hvad_er_kraeft_i_nyrebaekken_og_urinleder\"><\/span>Hvad er kr\u00e6ft i nyreb\u00e6kken og urinleder<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft11.jpg\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved planche med tegning af nyre med tumor.\" class=\"wp-image-25258\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft11.jpg 1024w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft11-300x300.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft11-100x100.jpg 100w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft11-600x600.jpg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft11-150x150.jpg 150w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft11-768x768.jpg 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Denne kr\u00e6ftform er en s\u00e6rlig diagnose, der ofte forveksles med almindelig nyrekr\u00e6ft, men biologisk er den helt anderledes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sygdommen opst\u00e5r ikke i selve nyrev\u00e6vet (der renser blodet), men i urotelet \u2013 den slimhinde, der bekl\u00e6der indersiden af urinvejene. Urinvejene fungerer som et r\u00f8rsystem:<\/p>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li>Urinen dannes i nyren.<\/li>\n\n\n\n<li>Den samles i et hulrum inde i nyren, kaldet nyreb\u00e6kkenet (pelvis renalis).<\/li>\n\n\n\n<li>Herfra l\u00f8ber den ned gennem et langt, tyndt r\u00f8r, urinlederen (ureter).<\/li>\n\n\n\n<li>Til sidst ender den i bl\u00e6ren.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">N\u00e5r der opst\u00e5r kr\u00e6ft i denne slimhinde i den \u00f8vre del af systemet (f\u00f8r bl\u00e6ren), kaldes det urotelialt karcinom i \u00f8vre urinveje. Da slimhinden er den samme i hele systemet, vil denne kr\u00e6ftform give en markant \u00f8get risiko for ogs\u00e5 at udvikle bl\u00e6rekr\u00e6ft.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Arsager\"><\/span>\u00c5rsager<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1280\" height=\"720\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft1.jpg\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved abstrakt figur med snoninger i r\u00f8d og bl\u00e5.\" class=\"wp-image-25253\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft1.jpg 1280w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft1-600x338.jpg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft1-300x169.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft1-1024x576.jpg 1024w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft1-768x432.jpg 768w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Ligesom ved bl\u00e6rekr\u00e6ft er det ofte stoffer, som kroppen udskiller gennem urinen, der skader slimhinden og starter kr\u00e6ftudviklingen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rygning<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dette er den absolut st\u00f8rste risikofaktor. De kr\u00e6ftfremkaldende stoffer fra tobakken optages i blodet, filtreres af nyrerne og koncentreres i urinen. Her ligger de i direkte kontakt med slimhinden i nyreb\u00e6kkenet og urinlederen og laver skader p\u00e5 cellernes DNA.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kemiske stoffer<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Erhvervsm\u00e6ssig uds\u00e6ttelse for visse kemikalier, is\u00e6r aromatiske aminer (brugt i plast-, farve- og gummiindustrien), \u00f8ger risikoen betydeligt.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Lynch Syndrom<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>I sj\u00e6ldne tilf\u00e6lde (under 5 %) er sygdommen arvelig. Personer med Lynch Syndrom (en genetisk fejl, der ogs\u00e5 giver \u00f8get risiko for tarmkr\u00e6ft) har en meget h\u00f8j risiko for at udvikle netop kr\u00e6ft i nyreb\u00e6kkenet eller urinlederen \u2013 ofte i en yngre alder end gennemsnittet.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Symptomer\"><\/span>Symptomer<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft10.jpg\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved en l\u00e6ge i hvid kittel og en patient der kigger p\u00e5 en sk\u00e6rm med en scanning.\" class=\"wp-image-25257\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft10.jpg 1024w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft10-300x300.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft10-100x100.jpg 100w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft10-600x600.jpg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft10-150x150.jpg 150w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft10-768x768.jpg 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Sygdommen opdages ofte, fordi den giver fysiske gener, men kan i starten v\u00e6re uden symptomer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Blod i urinen (H\u00e6maturi)<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dette er det klassiske symptom, som ses hos 75-80 % af patienterne. Blodet kan v\u00e6re synligt (r\u00f8dt\/brunt) eller mikroskopisk. Det er vigtigt at reagere p\u00e5, da synligt blod i urinen aldrig er normalt.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Flankesmerter<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Smerter i siden eller l\u00e6nden opst\u00e5r typisk, hvis svulsten vokser og blokerer passagen i den sn\u00e6vre urinleder. N\u00e5r urinen ikke kan l\u00f8be frit, stiger trykket i nyren (hydronefrose), hvilket giver en dump, borende smerte, der kan minde om milde nyrestensanfald.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Generelle symptomer<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>V\u00e6gttab, nattesved og tr\u00e6thed er tegn p\u00e5 fremskreden sygdom, men ses sj\u00e6ldnere i de tidlige stadier.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Diagnose-2\"><\/span>Diagnose<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft9.jpg\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved et mikroskop og en cellepr\u00f8ve i dette.\" class=\"wp-image-25256\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft9.jpg 1024w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft9-300x300.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft9-100x100.jpg 100w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft9-600x600.jpg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft9-150x150.jpg 150w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft9-768x768.jpg 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Da symptomerne minder om nyresten eller bl\u00e6rebet\u00e6ndelse, kr\u00e6ver det specialiserede unders\u00f8gelser at finde kr\u00e6ften.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><a href=\"https:\/\/jegharkraeft.dk\/ct-scanning\/\">CT-Urografi<\/a><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Dette er standarden for udredning. Det er en CT-scanning af nyrer og urinveje, hvor man giver kontraststof i en blod\u00e5re. Scanningen tages i flere faser, s\u00e5 man kan se pr\u00e6cis, hvordan nyrerne udskiller kontrasten, og om der er &#8220;udfyldninger&#8221; (svulster) i nyreb\u00e6kkenet eller urinlederen.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Ureteroskopi (kikkertunders\u00f8gelse) <\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">For at v\u00e6re helt sikker og for at tage en <a href=\"https:\/\/jegharkraeft.dk\/biopsi-kraeft\/\">v\u00e6vspr\u00f8ve<\/a> (biopsi), f\u00f8rer l\u00e6gen (under narkose) en lang, tynd kikkert op gennem urinr\u00f8ret, gennem bl\u00e6ren og helt op i urinlederen til nyren. Her kan man se svulsten direkte. Samtidig unders\u00f8ges bl\u00e6ren (<a href=\"https:\/\/jegharkraeft.dk\/cystoskopi\/\">cystoskopi)<\/a> for at udelukke, at der er tumorer der ogs\u00e5.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Behandling\"><\/span>Behandling<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft8.jpg\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved en operationsstue og en l\u00e6ge der holder et laparoskopisk i patientens mave.\" class=\"wp-image-25255\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft8.jpg 1024w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft8-300x300.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft8-100x100.jpg 100w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft8-600x600.jpg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft8-150x150.jpg 150w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft8-768x768.jpg 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Behandlingen er ofte mere omfattende end ved almindelig nyrekr\u00e6ft, fordi risikoen for, at sygdommen kommer igen i samme side, er meget h\u00f8j.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Nefroureterektomi (standardoperation) <\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">For de fleste patienter er den eneste sikre behandling at fjerne hele &#8220;systemet&#8221; i den syge side.  [4]<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Man fjerner:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Selve nyren.<\/li>\n\n\n\n<li>Hele urinlederen (fra nyre til bl\u00e6re).<\/li>\n\n\n\n<li>En lille &#8220;manchet&#8221; af bl\u00e6rev\u00e6ggen, hvor urinlederen munder ud. Dette g\u00f8res for at forhindre, at kr\u00e6ftceller drysser ned og s\u00e6tter sig i resterne af urinlederen. Operationen foretages ofte som kikkertkirurgi (robotassisteret).<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Organbevarende behandling <\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Hvis patienten kun har \u00e9n nyre, eller hvis nyrefunktionen er d\u00e5rlig, vil man fors\u00f8ge at undg\u00e5 at fjerne nyren.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Laserbehandling:<\/strong> Via kikkert (ureteroskop) kan man i nogle tilf\u00e6lde br\u00e6nde sm\u00e5, overfladiske tumorer v\u00e6k med laser.<\/li>\n\n\n\n<li><strong>Segment-resektion:<\/strong> Hvis tumoren sidder i den aller-nederste del af urinlederen, kan man n\u00f8jes med at fjerne det nederste stykke og sy urinlederen fast p\u00e5 bl\u00e6ren igen.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\"><a href=\"https:\/\/jegharkraeft.dk\/kemoterapi\/\">Kemoterapi<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Adjuverende (efterbehandling):<\/strong> Hvis svulsten var stor eller var vokset ind i muskellaget, tilbydes ofte kemoterapi (<a href=\"https:\/\/jegharkraeft.dk\/platinbaserede-laegemidler\/\">Cisplatin<\/a>) efter operationen for at neds\u00e6tte risikoen for tilbagefald.<\/li>\n\n\n\n<li><strong>Ved spredning:<\/strong> Hvis sygdommen har spredt sig til andre organer, er kemoterapi eller <a href=\"https:\/\/jegharkraeft.dk\/immunterapi\/\">immunterapi<\/a> den prim\u00e6re behandling.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Statistik\"><\/span>Statistik<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1280\" height=\"720\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft6.webp\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved bl\u00e5 opadg\u00e5ende pil p\u00e5 sort baggrund.\" class=\"wp-image-25248\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft6.webp 1280w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft6-600x338.webp 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft6-300x169.webp 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft6-1024x576.webp 1024w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft6-768x432.webp 768w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-esab-accordion esab-t1lk38m6\" data-mode=\"global\"><div class=\"esab__container\">\n<div class=\"wp-block-esab-accordion-child\"><div class=\"esab__head\" role=\"button\" aria-expanded=\"false\"><div class=\"esab__heading_txt\"><p class=\"esab__heading_tag\">Kr\u00e6ft i nyreb\u00e6kken og urinleder (Uroteliale tumorer i \u00f8vre urinveje\/UTUC) er langt sj\u00e6ldnere end bl\u00e6rekr\u00e6ft, men forekomsten er svagt stigende.<br><strong>L\u00e6s mere&#8230;<\/strong><\/p><\/div><div class=\"esab__icon\"><div class=\"esab__collapse\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m3.5 20.5c-4.7-4.7-4.7-12.3 0-17 4.7-4.7 12.3-4.7 17 0 4.6 4.7 4.6 12.3 0 17-4.7 4.6-12.3 4.6-17 0zm0.9-0.9c4.2 4.2 11 4.2 15.2 0 4.2-4.2 4.2-11 0-15.2-4.2-4.3-11-4.3-15.2 0-4.3 4.2-4.3 11 0 15.2z\"><\/path><path d=\"m11.4 15.9v-3.3h-3.3c-0.3 0-0.6-0.3-0.6-0.6 0-0.4 0.3-0.6 0.6-0.6h3.3v-3.3c0-0.3 0.3-0.6 0.6-0.6 0.3 0 0.6 0.3 0.6 0.6v3.3h3.3c0.3 0 0.6 0.2 0.6 0.6q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2h-3.3v3.3q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2c-0.4 0-0.6-0.3-0.6-0.6z\"><\/path><\/svg> <\/div><div class=\"esab__expand\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m12 24c-6.6 0-12-5.4-12-12 0-6.6 5.4-12 12-12 6.6 0 12 5.4 12 12 0 6.6-5.4 12-12 12zm10.6-12c0-5.9-4.7-10.6-10.6-10.6-5.9 0-10.6 4.7-10.6 10.6 0 5.9 4.7 10.6 10.6 10.6 5.9 0 10.6-4.7 10.6-10.6z\"><\/path><path d=\"m5.6 11.3h12.8v1.4h-12.8z\"><\/path><\/svg> <\/div><\/div><\/div><div class=\"esab__body\">\n<p class=\"wp-block-paragraph\"><strong>Incidens (nye tilf\u00e6lde)<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Der diagnosticeres \u00e5rligt ca. 270-300 nye tilf\u00e6lde i Danmark.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Fordeling:<\/strong> Ca. 2\/3 af tilf\u00e6ldene opst\u00e5r i nyreb\u00e6kkenet (pelvis), mens 1\/3 opst\u00e5r i selve urinlederen (ureter).<\/li>\n\n\n\n<li><strong>K\u00f8nsforskel:<\/strong> M\u00e6nd rammes dobbelt s\u00e5 hyppigt som kvinder.<\/li>\n\n\n\n<li><strong>Alder:<\/strong> Det er en sygdom, der prim\u00e6rt rammer \u00e6ldre. Medianalderen ved diagnosetidspunktet er 73 \u00e5r. Det ses uhyre sj\u00e6ldent hos personer under 50 \u00e5r.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Sammenh\u00e6ng med bl\u00e6rekr\u00e6ft<\/strong> <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Der er en st\u00e6rk statistisk sammenh\u00e6ng mellem kr\u00e6ft i \u00f8vre og nedre urinveje:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Omvendt har patienter med bl\u00e6rekr\u00e6ft en risiko p\u00e5 2-6 % for at udvikle kr\u00e6ft i nyreb\u00e6kkenet eller urinlederen.<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Patienter med kr\u00e6ft i nyreb\u00e6kken\/urinleder har en risiko p\u00e5 22-47 % for senere at udvikle kr\u00e6ft i bl\u00e6ren.<\/li>\n<\/ul>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Prognose\"><\/span>Prognose<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"576\" height=\"559\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft12.jpg\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved scanningsbillede af mave og underliv. hvor der peges p\u00e5 et omr\u00e5de der er kranset ind i r\u00f8dt.\" class=\"wp-image-25259\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft12.jpg 576w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft12-300x291.jpg 300w\" sizes=\"auto, (max-width: 576px) 100vw, 576px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-esab-accordion esab-w8xjb5ia\" data-mode=\"global\"><div class=\"esab__container\">\n<div class=\"wp-block-esab-accordion-child\"><div class=\"esab__head\" role=\"button\" aria-expanded=\"false\"><div class=\"esab__heading_txt\"><p class=\"esab__heading_tag\">Prognosen er st\u00e6rkt afh\u00e6ngig af to faktorer: Stadiet (hvor dybt tumoren vokser) og graden (hvor aggressiv cellen er). Da v\u00e6ggen i urinlederen og nyreb\u00e6kkenet er meget tynd, kan kr\u00e6ften lettere vokse igennem end i den tykke bl\u00e6rev\u00e6g.<br><strong>L\u00e6s mere&#8230;<\/strong><\/p><\/div><div class=\"esab__icon\"><div class=\"esab__collapse\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m3.5 20.5c-4.7-4.7-4.7-12.3 0-17 4.7-4.7 12.3-4.7 17 0 4.6 4.7 4.6 12.3 0 17-4.7 4.6-12.3 4.6-17 0zm0.9-0.9c4.2 4.2 11 4.2 15.2 0 4.2-4.2 4.2-11 0-15.2-4.2-4.3-11-4.3-15.2 0-4.3 4.2-4.3 11 0 15.2z\"><\/path><path d=\"m11.4 15.9v-3.3h-3.3c-0.3 0-0.6-0.3-0.6-0.6 0-0.4 0.3-0.6 0.6-0.6h3.3v-3.3c0-0.3 0.3-0.6 0.6-0.6 0.3 0 0.6 0.3 0.6 0.6v3.3h3.3c0.3 0 0.6 0.2 0.6 0.6q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2h-3.3v3.3q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2c-0.4 0-0.6-0.3-0.6-0.6z\"><\/path><\/svg> <\/div><div class=\"esab__expand\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m12 24c-6.6 0-12-5.4-12-12 0-6.6 5.4-12 12-12 6.6 0 12 5.4 12 12 0 6.6-5.4 12-12 12zm10.6-12c0-5.9-4.7-10.6-10.6-10.6-5.9 0-10.6 4.7-10.6 10.6 0 5.9 4.7 10.6 10.6 10.6 5.9 0 10.6-4.7 10.6-10.6z\"><\/path><path d=\"m5.6 11.3h12.8v1.4h-12.8z\"><\/path><\/svg> <\/div><\/div><\/div><div class=\"esab__body\">\n<p class=\"wp-block-paragraph\"><strong>Overlevelse baseret p\u00e5 stadier (5-\u00e5rs overlevelse)<\/strong> <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tallene herunder er baseret p\u00e5 patologisk stadieinddeling efter operation [3]:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>pTa \/ pT1 (overfladisk sygdom):<\/strong> Tumoren sidder kun i slimhinden eller bindev\u00e6vet lige under. Her er prognosen god med en 5-\u00e5rs overlevelse p\u00e5 over 90 %.<\/li>\n\n\n\n<li><strong>pT2 (muskelinvasiv):<\/strong> Tumoren er vokset ind i muskellaget omkring nyreb\u00e6kken eller urinleder. 5-\u00e5rs overlevelsen falder her til ca. 60-75 %.<\/li>\n\n\n\n<li><strong>pT3 (gennemv\u00e6kst):<\/strong> Tumoren er vokset igennem muskellaget og ud i det omkringliggende fedtv\u00e6v eller nyrev\u00e6v. 5-\u00e5rs overlevelsen er ca. 40-54 %.<\/li>\n\n\n\n<li><strong>pT4 \/ N+ (spredning):<\/strong> Hvis tumoren vokser ind i naboorganer, eller der er spredning til lymfeknuder (N+), er sygdommen alvorlig. 5-\u00e5rs overlevelsen er her under 10-15 %, og behandlingen er prim\u00e6rt livsforl\u00e6ngende.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Betydningen af &#8220;Grading&#8221; (low vs. high grade)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Low grade:<\/strong> Cellerne ligner n\u00e6sten normale celler og vokser langsomt. Disse tumorer spreder sig sj\u00e6ldent (under 5 % risiko for spredning), men har tendens til at komme igen lokalt.<\/li>\n\n\n\n<li><strong>High grade:<\/strong> Aggressive celler. Ca. 60 % af patienterne med high grade tumorer har invasiv v\u00e6kst eller spredning allerede ved diagnosetidspunktet.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Risiko for tilbagefald (<\/strong><a href=\"https:\/\/jegharkraeft.dk\/ved-recidiv\/\">recidiv<\/a><strong>)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Selv efter fjernelse af nyre og urinleder er man ikke &#8220;fredet&#8221;. Sygdommen har en &#8220;pan-urotelial&#8221; karakter, hvilket betyder, at hele slimhinden i urinvejene er ustabil.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Lokalrecidiv:<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tilbagefald i det omr\u00e5de, hvor nyren sad, er sj\u00e6ldent (under 5-10 %), hvis kirurgen har f\u00e5et alt v\u00e6v med.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bl\u00e6rerecidiv:<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Som n\u00e6vnt udvikler op mod halvdelen af patienterne tumorer i bl\u00e6ren inden for de f\u00f8rste 2-3 \u00e5r. Derfor er kikkertunders\u00f8gelse af bl\u00e6ren (cystoskopi) obligatorisk i opf\u00f8lgningsprogrammet.<\/li>\n<\/ul>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Alternative_tiltag\"><\/span>Alternative tiltag<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"793\" height=\"1280\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft4.webp\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved skitse af nyre og \u00f8verste del af urinleder.\" class=\"wp-image-25250\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft4.webp 793w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft4-600x968.webp 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft4-186x300.webp 186w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft4-634x1024.webp 634w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft4-768x1240.webp 768w\" sizes=\"auto, (max-width: 793px) 100vw, 793px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Der er rapporteret kr\u00e6fttilf\u00e6lde med gode resultater for komplement\u00e6re tiltag \u2013 ikke mindst som supplerende til konventionel behandling. Dette g\u00e6lder ikke mindst anvendelse af <a href=\"https:\/\/jegharkraeft.dk\/repurposed-drugs\/\">Repurposed drugs<\/a>, herunder <a href=\"https:\/\/jegharkraeft.dk\/coc-protokollen\/\">COC-Protokollen<\/a>. Men der findes i \u00f8vrigt omfattende protokoller for metabolisk blokering af kr\u00e6ftens energi- og signalveje. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Endvidere kan du overveje at supplere din konventionelle behandling med mere komplement\u00e6re behandlinger, hvis du har f\u00e5et diagnosen kr\u00e6ft. At f\u00f8le at man har indflydelse p\u00e5 udfaldet af behandling giver styrke og reducerer f\u00f8lelsen af at miste kontrollen over sit liv.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/metabolisk-blaerekraeft\/\">Bl\u00e6rekr\u00e6ft og UTUC (nyreb\u00e6kken\/ urinleder)<\/a> &#8211; metabolisk blokering<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/livskvalitet-og-medansvar-beslutningen\/\">Livskvalitet og medansvar<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Konklusion\"><\/span>Konklusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1280\" height=\"853\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft3.jpg\" alt=\"Nyreb\u00e6kken- og Urinlederkr\u00e6ft symboliseret ved et gyldent ahornblad med flere blade bag.\" class=\"wp-image-25251\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft3.jpg 1280w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft3-600x400.jpg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft3-300x200.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft3-1024x682.jpg 1024w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Nyrebaekken-og-Urinlederkraeft3-768x512.jpg 768w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Kr\u00e6ft i nyreb\u00e6kken og urinleder er en alvorlig sygdom, der kr\u00e6ver hurtig handling ved symptomer som blod i urinen. Behandlingen er ofte radikal med fjernelse af en nyre, men dette giver s\u00e5 samtidig den bedste mulighed for helbredelse. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Livslang kontrol er n\u00f8dvendig, da slimhinden i bl\u00e6ren fortsat er i risiko.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/beslutningen\"><strong>Beslutningen<\/strong><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/alternative-oversigt\"><strong>Alternative Behandlinger Oversigt<\/strong><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/nyrekraeft\"><strong>Nyrekr\u00e6ft<\/strong><\/a><\/p>\n\n\n\n<p class=\"has-custom-menu-links-color has-text-color has-link-color wp-elements-78958270cc4840b7bdca48105c79180e wp-block-paragraph\"><strong><a href=\"#menu\" data-type=\"internal\" data-id=\"#diagnose\">(Til menu)<\/a><\/strong><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Links<\/h4>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-879caa4008e4267d0260c391631b217c wp-block-paragraph\">[1] <a href=\"https:\/\/www.sundhed.dk\/borger\/patienthaandbogen\/nyrer-og-urinveje\/sygdomme\/andre-urinvejssygdomme\/kraeftsygdom-i-oevre-urinveje\/\" target=\"_blank\" rel=\"noopener\">Kr\u00e6ftsygdom i \u00f8vre urinveje<\/a> (Sundhed.dk, 2024) <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En opdateret patientinformation, der beskriver kr\u00e6ft i nyreb\u00e6kken og urinleder. Artiklen forklarer, at sygdommen udg\u00e5r fra samme slimhinde som bl\u00e6rekr\u00e6ft, og gennemg\u00e5r symptomer som blod i urinen samt principperne for udredning og behandling.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0e9abfeab6580e1fa27e08675be5fac8 wp-block-paragraph\">[2] <a href=\"https:\/\/www.sst.dk\/udgivelser\/2020\/pakkeforloeb-for-kraeft-i-urinvejene\" target=\"_blank\" rel=\"noopener\">Pakkeforl\u00f8b for kr\u00e6ft i urinvejene<\/a> (Sundhedsstyrelsen, 2020)<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> De nationale retningslinjer, der sikrer hurtig udredning ved synligt blod i urinen. Dokumentet beskriver kriterierne for henvisning og standardbehandlingen med fjernelse af nyre og urinleder.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5018626ac546885ab9c804c26b861847 wp-block-paragraph\">[3] <a href=\"https:\/\/www.dmcg.dk\/siteassets\/kliniske-retningslinjer\/opdelt-paa-dmcg\/blarecancer\/dablaca_uroteliale_tum_ovre_v.1.1_admgodk_140825.pdf\" target=\"_blank\" rel=\"noopener\">Uroteliale tumorer i \u00f8vre urinveje<\/a> (Danske Multidisciplin\u00e6re Cancer Grupper, Dansk Bl\u00e6re Cancer Gruppe &#8211; DaBlaCa, 2025) <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> De nationale kliniske retningslinjer for udredning og behandling. Dokumentet indeholder detaljerede data om stadieinddeling, prognostiske faktorer samt risikoen for tilbagefald i bl\u00e6ren, hvilket danner grundlag for den danske behandlingsstrategi.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ce91544873dd54689a40f9378ffcdfdb wp-block-paragraph\">[4] <a href=\"https:\/\/www.rigshospitalet.dk\/undersoegelse-og-behandling\/find-undersoegelse-og-behandling\/sider\/nefroureterektomi-31122.aspx\" target=\"_blank\" rel=\"noopener\">Nefroureterektomi<\/a> (Rigshospitalet, ej dateret)<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Proceduren ved fjernelse af nyre og urinleder.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Siden er oprettet:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">d. 30.11.25<a href=\"https:\/\/jegharkraeft.dk\/second-opinion\"><\/a><\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">\u2764<\/mark><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hvad du l\u00e6ser p\u00e5 <\/strong><em><strong>Jeg har Kr\u00e6ft<\/strong><\/em><strong> er ikke en anbefaling. S\u00f8g kompetent vejledning.<\/strong><\/p>\n<\/div>\n<\/div>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Indhold<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><ul class='ez-toc-list-level-2' ><li class='ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Diagnose\" >Diagnose<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Nyrebaekken-_og_Urinlederkraeft\" >Nyreb\u00e6kken- og Urinlederkr\u00e6ft<\/a><ul class='ez-toc-list-level-2' ><li class='ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Hvad_er_kraeft_i_nyrebaekken_og_urinleder\" >Hvad er kr\u00e6ft i nyreb\u00e6kken og urinleder<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Arsager\" >\u00c5rsager<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Symptomer\" >Symptomer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Diagnose-2\" >Diagnose<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Behandling\" >Behandling<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Statistik\" >Statistik<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Prognose\" >Prognose<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Alternative_tiltag\" >Alternative tiltag<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/jegharkraeft.dk\/en\/nyrebaekken-og-urinlederkraeft\/#Konklusion\" >Konklusion<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Diagnose Nyreb\u00e6kken- og Urinlederkr\u00e6ft Resum\u00e9 om kr\u00e6ft i nyreb\u00e6kken og urinleder Sj\u00e6lden placering: Vigtigste signal: Omfattende operation: Hvad er kr\u00e6ft i nyreb\u00e6kken og urinleder Denne kr\u00e6ftform er en s\u00e6rlig diagnose, der ofte forveksles med almindelig nyrekr\u00e6ft, men biologisk er den helt anderledes. Sygdommen opst\u00e5r ikke i selve nyrev\u00e6vet (der renser blodet), men i urotelet \u2013 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":25252,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[99,88,91],"tags":[],"class_list":["post-25245","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-andre-organer","category-diagnose","category-kraefttyper"],"modified_by":"Hanne","wpml_current_locale":"da_DK","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts\/25245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/comments?post=25245"}],"version-history":[{"count":0,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts\/25245\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/media\/25252"}],"wp:attachment":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/media?parent=25245"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/categories?post=25245"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/tags?post=25245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}